Guidance for market authorization requirements for COVID-19 vaccines: Quality, manufacturing and lot release requirements (English, HTML)

View metadata and access the original English HTML file: Guidance for market authorization requirements for COVID-19 vaccines: Quality, manufacturing and lot release requirements.

Format

HTML

Access

file-only

Publisher-reported update

2021-07-29

COVID-19 vaccines must be manufactured under good manufacturing practices (GMP) conditions. These conditions must be in line with international requirements, which are outlined in the International Council for Harmonization Q7A guideline and applicable Health Canada guidance.

Access original file